NCT01627886View on ClinicalTrials.gov

Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions
Healthy
Interventions
DRUG

Ibandronate sodium

Ibandronate sodium Tablets 150 mg

Trial Locations (1)

380 054

BA Research India Ltd, Ahmedabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY